Large-scale testing (Phase 3)Study completedNCT00086112
What this trial is testing
Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Who this might be right for
Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 301